Home > Insider Trading > Filing (0001209191-10-030788)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1472595	Accretive Health Inc.	AH	Services-Management Services (8741)	020698101

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1201677	Michael J Cline	C/O Accretive Health, Inc. 401 North Michigan Avenue, Suite 2700 Chicago IL 60611		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-05-25	20,908,996	$0.00	20,908,996	No	4	C	Indirect	See Footnote
Common Stock	Disposition	2010-05-25	995,348	$11.28	19,913,648	No	4	S	Indirect	See Footnote
Common Stock	Acquisiton	2010-05-25	603,218	$12.00	20,516,866	No	4	J	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	J	Indirect	See Footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2010-05-25	15,927	$0.00	19,136,400	$0.00
Common Stock	Series D Convertible Preferred Stock	Disposition	2010-05-25	452,193	$0.00	1,772,596	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

The Reporting Person is the managing member of Accretive Associates SBIC, LLC, which is the general partner of Accretive Investors SBIC, L.P. ("Accretive Investors"). Accretive Investors is the beneficial owner of the shares of common stock. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the Accretive Investors shares in which the Reporting Person has no actual pecuniary interest.
Reflects shares of Common Stock received in satisfaction of a liquidation preference payment required to be paid to Accretive Investors upon the closing of the Issuer's initial public offering.
The Series A Convertible Preferred Stock automatically converted into the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 1,201.5069 for one basis and had no expiration date.
The Series D Convertible Preferred Stock automatically converted into the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering on a 3.92 for one basis and had no expiration date.